Phase 1 Study of Voyager’s Gene Therapy Shows Potential for Parkinson’s Patients – Parkinson’s News Today
|
Phase 1 Study of Voyager’s Gene Therapy Shows Potential for Parkinson’s Patients
Parkinson’s News Today To overcome the defect of AADC levels in neurons, Voyager Therapeutics developed a targeted gene therapy to directly deliver and promote the expression of the enzyme in a brain region called the putamen. Because patients with advance Parkinson’s … |
|
Phase 1 Study of Voyager’s Gene Therapy Shows Potential for Parkinson’s Patients
Parkinson’s News Today To overcome the defect of AADC levels in neurons, Voyager Therapeutics developed a targeted gene therapy to directly deliver and promote the expression of the enzyme in a brain region called the putamen. Because patients with advance Parkinson’s … |
Medical Xpress |
Transparent bones enable researchers to observe the stem cells inside
Medical Xpress “Because of the sparsity of the stem cell population in the bone, it is challenging to extrapolate their numbers and positions from just a few slices of bone,” says Alon Greenbaum, postdoctoral scholar in biology and biological engineering and co-first … Scientists turn bones transparent to let them see into marrow – StatSTAT |
Medgadget (blog) |
Global Gene Therapy Market 2017 : Sibiono GeneTech, Advantagene, UniQure NV, Sangamo, Spark Therapeutics
Medgadget (blog) The Global Gene Therapy Market Key Vendors are Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Sibiono GeneTech, Advantagene, UniQure NV. The report, named “Global Gene Therapy Market“, provides a … |
Medgadget (blog) |
Global Gene Therapy Market 2017 : Sibiono GeneTech, Advantagene, UniQure NV, Sangamo, Spark Therapeutics
Medgadget (blog) The Global Gene Therapy Market Key Vendors are Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Sibiono GeneTech, Advantagene, UniQure NV. The report, named “Global Gene Therapy Market“, provides a … |